This site is intended for Healthcare Professionals only.

Search results for: novartis

Novartis scraps sale of £805m assets including Covid-19 hopeful to Aurobindo

Novartis AG on Thursday  (2) scrapped the $1 billion (£0.81bn) sale of US generic pill and skin drug assets to India's Aurobindo Pharma Ltd as...

NHS confirms deal with Novartis to fund treatment for rare periodic fever syndromes

NHS England has confirmed a deal with Novartis to fund a life-changing treatment for people with rare conditions which cause repeated bouts of fever,...

UK to be Novartis’ global centre for cardio trial

Swiss pharma giant Novartis has chosen the UK as its global centre for a major cardiovascular trial. The trial will investigate the use of inclisiran...

Novartis 2019 profits dip; Pfizer reports 4Q loss

Swiss pharmaceuticals giant Novartis on Wednesday reported a drop in net profit in 2019 -- a year marked by large-scale restructuring -- but saw...

Drugmaker Sandoz to pay $265m to settle US pricing case

Swiss generic drugmaker Sandoz said on Thursday that it would pay $265 million (£209m) to settle a pricing antitrust case in the US. Under the...

EMA recommends approving GSK’s oral therapy for rare blood cancer

A decision on EU marketing authorisation for oral therapy is expected by early 2024. The Committee for Medicinal Products for Human Use (CHMP) of...